Breakthrough in Cancer Therapy Results in Accumulation of Drugs in Cancer Cells

Dr. Cheng from the University of IL has developed a cancer drug delivery strategy which could result in delivery and activation of the chemotherapeutic agent specifically in cancer cells. Most cancer drugs are extremely toxic; they attack cancer cells preferentially but have deleterious effects on normal cells. Dr. Cheng's group has developed a strategy which uses cancer-specific biomolecules to pre-label the cancer cells. When chemotherapy is subsequently administered, these pre-marked cells serve as beacons to attract and trap the cancer drugs specifically in tumor cells.